Tutorial in biostatistics: sample sizes for parallel group clinical trials with binary data

This article gives an overview of sample size calculations for a single response and a comparison of two responses in a parallel group trial where the outcome is binary. Sample size derivation is given for trials where the objective is to demonstrate: superiority, equivalence, non-inferiority and estimation to a given precision. For each type of trial the null and alternative hypotheses are described and how the impact these have on the sample size calculations. For each type of trial the calculations are highlighted through worked examples. Sample size tables for the different types of trials and worked examples are given to assist in future calculations.

[1]  Robert A. Muenchen,et al.  Help and Documentation , 2010 .

[2]  Steven A. Julious,et al.  Sample Sizes for Clinical Trials , 2009 .

[3]  T. Morikawa,et al.  A useful testing strategy in phase III trials: combined test of superiority and test of equivalence. , 1995, Journal of biopharmaceutical statistics.

[4]  P. A. R. Koopman,et al.  Confidence intervals for the ratio of two binomial proportions , 1984 .

[5]  S. Julious.  The ABC of non‐inferiority margin setting from indirect comparisons , 2011, Pharmaceutical statistics.

[6]  E. S. Pearson,et al.  On the Problem of the Most Efficient Tests of Statistical Hypotheses , 1933 .

[7]  W. Ambrosius,et al.  Power for studies with random group sizes , 2010, Statistics in medicine.

[8]  C. Dunnett,et al.  Significance testing to establish equivalence between treatments, with special reference to data in the form of 2X2 tables. , 1977, Biometrics.

[9]  T R Fleming,et al.  One-sample multiple testing procedure for phase II clinical trials. , 1982, Biometrics.

[10]  Toshimitsu Hamasaki,et al.  Sample size determination in clinical trials with multiple co‐primary binary endpoints , 2010, Statistics in medicine.

[11]  S. Julious,et al.  The ABC of pharmaceutical trial design: some basic principles , 2002 .

[12]  D. Altman,et al.  Indirect comparison meta-analysis of aspirin therapy after coronary surgery , 2003, BMJ : British Medical Journal.

[13]  Yi Tsong,et al.  Some fundamental issues with non‐inferiority testing in active controlled trials , 2002, Statistics in medicine.

[14]  R. Berger,et al.  Bioequivalence trials, intersection-union tests and equivalence confidence sets , 1996 .

[15]  E. Korn.  Sample size tables for bounding small proportions. , 1986, Biometrics.

[16]  R. Newcombe,et al.  Interval estimation for the difference between independent proportions: comparison of eleven methods. , 1998, Statistics in medicine.

[17]  Evaluation of the statistical power for multiple tests: a case study , 2009, Pharmaceutical statistics.

[18]  D. Altman,et al.  Estimating sample sizes for continuous, binary, and ordinal outcomes in paired comparisons: practical hints. , 1999, Journal of biopharmaceutical statistics.

[19]  J Wood,et al.  Sample Size Calculations for Trials in Health Services Research , 1999, Journal of health services research & policy.

[20]  David Machin,et al.  Sample Size Tables for Clinical Studies , 1997 .

[21]  J A Lewis,et al.  Trials to assess equivalence: the importance of rigorous methods , 1996, BMJ.

[22]  B. Wiens,et al.  Choosing an equivalence limit for noninferiority or equivalence studies. , 2002, Controlled clinical trials.

[23]  Rolf Lefering,et al.  Probability of adverse events that have not yet occurred: a statistical reminder , 1995, BMJ.

[24]  J M Bland,et al.  Statistics Notes: One and two sided tests of significance , 1994 .

[25]  L. Daly,et al.  Simple SAS macros for the calculation of exact binomial and Poisson confidence limits. , 1992, Computers in biology and medicine.

[26]  Steven A Julious,et al.  A comparison of methods for sample size estimation for non-inferiority studies with binary outcomes , 2011, Statistical methods in medical research.

[27]  Petter Laake,et al.  Recommended tests for association in 2×2 tables , 2009, Statistics in medicine.

[28]  Shein-Chung Chow,et al.  Sample Size Calculations in Clinical Research, Second Edition , 2003 .

[29]  Jerzy Neyman,et al.  The testing of statistical hypotheses in relation to probabilities a priori , 1933, Mathematical Proceedings of the Cambridge Philosophical Society.

[30]  H. Sahai,et al.  Formulae and tables for the determination of sample sizes and power in clinical trials for testing differences in proportions for the two-sample design: a review. , 1996, Statistics in medicine.

[31]  E. S. Pearson,et al.  CONTRIBUTIONS TO THE THEORY OF TESTING STATISTICAL HYPOTHESES , 1967, Joint Statistical Papers.

[32]  H. Fallahzadeh.  ESTIMATING SAMPLE SIZES FOR BINARY, ORDERED CATEGORICAL, AND CONTINUOUS OUTCOMES IN TWO GROUP COMPARISONS , 2010 .

[33]  S. Julious.  Two‐sided confidence intervals for the single proportion: comparison of seven methods by Robert G. Newcombe, Statistics in Medicine 1998; 17:857–872 , 2005, Statistics in medicine.

[34]  Steven A. Julious,et al.  How Biased are Indirect Comparisons, Particularly When Comparisons are Made over Time in Controlled Trials? , 2008 .

[35]  A. Kirkwood,et al.  Choice of control group in clinical trials: prospective or retrospective , 2013 .

[36]  H M James Hung,et al.  TACT method for non‐inferiority testing in active controlled trials , 2002, Statistics in medicine.

[37]  Frank Bretz,et al.  Power and sample size when multiple endpoints are considered , 2007, Pharmaceutical statistics.

[38]  R. Newcombe.  Two-sided confidence intervals for the single proportion: comparison of seven methods. , 1998, Statistics in medicine.

[39]  C. Farrington,et al.  Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk. , 1990, Statistics in medicine.

[40]  David F. Kong,et al.  Statistical Methods for Comparison to Placebo in Active-Control Trials , 2001 .

[41]  S. Julious.  Sample sizes for clinical trials with Normal data , 2004, Statistics in medicine.

[42]  Douglas G Altman,et al.  Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses , 2003, BMJ : British Medical Journal.

[43]  R. D'Agostino,et al.  Non‐inferiority trials: design concepts and issues – the encounters of academic consultants in statistics , 2002, Statistics in medicine.

[44]  Steven M Snapinn,et al.  Alternatives for Discounting in the Analysis of Noninferiority Trials , 2004, Journal of biopharmaceutical statistics.

[45]  E. S. Pearson,et al.  THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIAL , 1934 .

[46]  Steven A. Julious,et al.  Sample sizes for estimation in clinical research , 2004 .

[47]  M Nurminen,et al.  Comparative analysis of two rates. , 1985, Statistics in medicine.

[48]  Hiroshi Nishiyama,et al.  Points to consider on switching between superiority and non-inferiority. , 2006, British journal of clinical pharmacology.

[49]  J. Seaman.  Sample Size Methodology , 2012 .

[50]  CLINICAL TRIAL NUMBERS AND CONFIDENCE INTERVALS OF PRE-SPECIFIED SIZE , 1988, The Lancet.

[51]  M E Halloran,et al.  Augmented HIV vaccine trial design for estimating reduction in infectiousness and protective efficacy. , 1998, Statistics in medicine.

[52]  J. Richardson,et al.  The analysis of 2 × 1 and 2 × 2 contingency tables: an historical review , 1994, Statistical methods in medical research.

[53]  Yi Tsong,et al.  Utility and pitfalls of some statistical methods in active controlled clinical trials. , 2002, Controlled clinical trials.